Lipozem Reviews (BUYER ALERT!) Is It Legit And Safe To Use? Consumer Report On Reddit Breaks It Down!
MIAMI, April 12, 2025 (GLOBE NEWSWIRE) -- The Lipozem weight loss supplement has been garnering attention in the weight loss...
Brain
Weekly Recap: 15 Health Press Releases You Need to See
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Google Cloud's commitment to AI-powered...
Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting
– Clinically Meaningful Efficacy Observed on Multiple Assessments – – Confirmed Target Engagement with Reduced Iron Signal in MSA Affected...
ALS Association Partners with Schoox to Enhance Learning for Healthcare Providers, Caregivers, and People Living With ALS
Schoox will deliver access to educational resources, programs, certification courses, and more. AUSTIN, Texas, April 9, 2025 /PRNewswire/ -- Schoox, a...
Biomed 2025, Israel’s Leading Annual Life Science Conference and Exhibition, to Take Place May 20-22, in Tel Aviv
Plenary session includes investment panel featuring global bankers and VCs TEL AVIV, Israel, April 9, 2025 /PRNewswire/ -- Biomed Israel,...
Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial
SARASOTA, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel...
Arialief Supplement: Vitamins Reviews and Complaints for Neuropathic Pain
HONOLULU, April 09, 2025 (GLOBE NEWSWIRE) -- Arialief is a premium dietary supplement specifically designed to target the root causes...
Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104
NDA Submission Anticipated Q2 Calendar 2025PRINCETON, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics...
AFFOA Names Nuream and Z-Polymers the New Awardees of the Product Accelerator for Advanced Fabrics 2.0
CAMBRIDGE, Mass., April 8, 2025 /PRNewswire/ -- Advanced Functional Fabrics of America, Inc. (AFFOA) proudly announces Nuream and Z-Polymers as...
Brainomix Advances Stroke Care with Landmark FDA Clearance
Brainomix 360 unlocks expert-level insights from universally available non-contrast CT scans, helping stroke networks expand access to life-changing treatmentsOXFORD, England...
Kandu Health and Neurolutions Merge to Form Kandu, Inc., a New Leader in Stroke Recovery
Kandu, Inc. Announces $30 Million Financing to Advance Stroke Recovery and Rehabilitation VAN NUYS, Calif.--(BUSINESS WIRE)--KanduTM Health, Inc. and Neurolutions,...
Rapid Dose Therapeutics Provides Update on the Clinical Trial Development and the Commitment to NFL Funded Cannabinoid Research
Burlington, Ontario--(Newsfile Corp. - April 8, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotech...
Quibim Announces New Board of Directors To Promote Growth And Strategic Expansion
NEW YORK & VALENCIA, Spain & CAMBRIDGE, England--(BUSINESS WIRE)--#AIinHealthcare--Quibim, the global pioneer in imaging biomarkers for precision medicine, is pleased...
CAS and Cleveland Clinic collaborate to accelerate research through advanced AI and quantum computing
COLUMBUS, Ohio, April 7, 2025 /PRNewswire/ -- CAS, a division of the American Chemical Society specializing in scientific content and...
2025 ZGC Forum: Gala for Global Sci-tech Cooperation
BEIJING, April 7, 2025 /PRNewswire/ -- A report from Science and Technology Daily: The 2025 Zhongguancun Forum Annual Conference (2025 ZGC...
Cala Presents Multiple Clinical Studies Demonstrating Impact of Transcutaneous Afferent Patterned Stimulation (TAPS) Therapy in Essential Tremor (ET) Patients at the American Academy of Neurology (AAN)
SAN MATEO, Calif., April 7, 2025 /PRNewswire/ -- Cala, the bioelectronic medicine leader, who recently raised an oversubscribed growth financing round...
Make Time Wellness Announces Launch of Award-Winning Products at The Vitamin Shoppe
New Wellness Solutions Available Starting April 2025, Empowering Women to Prioritize Their Brain Health LOS ANGELES, April 7, 2025 /PRNewswire/...
UK Pilot launched to detect early signs of dementia & improve brain health
The Pilot Program uses a unique "Human + AI" (HAI) model to interact with patients & monitor progress. LONDON, April...
European Commission approves subcutaneous RYBREVANT®▼ (amivantamab) for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer
Subcutaneous (SC) amivantamab offers patients greater convenience, reducing administration time from hours to minutes and with a five-fold reduction in...
NKGen Biotech Presents Data from Phase 1/2a Clinical Trial of Troculeucel in Moderate Alzheimer’s Disease at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)
Moderate Alzheimer’s disease (AD) patients in the trial received the highest dose of troculeucel to date at 6 billion cells...